Tests a digital memory training program in children with sickle cell disease
Tests a digital working memory training program with support in youth with sickle cell disease.
Key facts
- Who runs it
- Children's National Research Institute
- Where
- Washington D.C., United StatesSee the site
- Trial code
- Registry title
- Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 5 Mar 2025
- Planned end
- 1 Apr 2026
- Type of study
- Interventional
- Treatments tested
- Cogmed+
- Record updated
- 13 February 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers aged 7-16 years with sickle cell disease. It tests a computer-based memory training program, with added social support and memory strategy training.
- Age
- 7 to 16 years
- Sex
- All sexes can join.
- Disease stage
- Sickle cell disease of any genotype.
- Earlier treatment
- People who recently started or changed the dose of a stimulant medication for attention problems (less than 30 days ago) cannot join.
- Biomarker or test result
- To enter the treatment phase, a person must score more than 1 SD below the normative mean on at least one standardized working memory test (Digit Span or Spatial Span), or show a relative weakness in working memory (more than 1 SD below the estimated IQ).
Main reasons for not taking part
- Movement, vision or hearing problem that prevents using a computer
- Mental health condition that rules out or takes priority over the cognitive training
- History of photosensitive seizures
- Not enough English fluency
- Stimulant medication for attention problems started or changed in the last 30 days
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Diagnosis of sickle cell disease (any genotype)
- Between ages 7-16 years old
- Patients will only enter the treatment phase if they score >1 SD below the normative mean on at least one standardized working memory assessment (i.e., Digit Span or Spatial Span subtests) or demonstrate a relative weakness in working memory (>1 SD below the estimated IQ)
Who cannot take part
- Recent initiation or dose adjustment of a stimulant medication to treat attention problems (< 30 days)
- Motor, visual, or auditory impairment that prevents computer use
- Diagnosis of a mental health condition that precludes, or takes treatment precedence over, participation in the cognitive training
- History of photosensitive seizures
- Insufficient English fluency
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 7 and 16 years old?
Where in United States
- Children's National HospitalWashington D.C., United StatesContact: Steven Hardy, PhDTaking people
About the trial
What the trial wants to find out
This is a single site nonrandomized pilot clinical trial of the feasibility, acceptability, and efficacy of a combination treatment involving digital Cogmed working memory skills training, social support components, and memory strategy training to improve adherence to Cogmed in youth with sickle cell disease ages 7-16 years.
The group in the trial
- Cogmed+Treatment being tested
Home-based digital cognitive rehabilitation and memory strategy training targeting working memory functioning.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell (ALL IN)
- Plain-language title
- Tests a digital memory training program in children with sickle cell diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06770010, who can take part
- Record updated
- 13 February 2025